Cargando…
Altered purinergic receptor expression in the frontal cortex in schizophrenia
ATP functions as a neurotransmitter, acting on the ubiquitously expressed family of purinergic P2 receptors. In schizophrenia (SCZ), the pathways that modulate extracellular ATP and its catabolism to adenosine are dysregulated. However, the effects of altered ATP availability on P2 receptor expressi...
Autores principales: | Alnafisah, Rawan, Lundh, Anna, Asah, Sophie M., Hoeflinger, Julie, Wolfinger, Alyssa, Hamoud, Abdul-rizaq, McCullumsmith, Robert E., O’Donovan, Sinead M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663420/ https://www.ncbi.nlm.nih.gov/pubmed/36376358 http://dx.doi.org/10.1038/s41537-022-00312-1 |
Ejemplares similares
-
Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?
por: Hamoud, Abdul-Rizaq, et al.
Publicado: (2022) -
Gene Enrichment Analysis of Astrocyte Subtypes in Psychiatric Disorders and Psychotropic Medication Datasets
por: Zhang, Xiaolu, et al.
Publicado: (2022) -
Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia
por: Sullivan, Courtney R., et al.
Publicado: (2018) -
Ampa Receptor Subunit Expression in the Endoplasmic Reticulum in Frontal Cortex of Elderly Patients with Schizophrenia
por: Hammond, John C., et al.
Publicado: (2012) -
Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS
por: O’Donovan, Sinead M, et al.
Publicado: (2020)